RETRACTION: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment (vol 89, pg 761, 2022) (Retraction of Vol 89, Pg 761, 2022)
CANCER CHEMOTHERAPY AND PHARMACOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined